Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-GLS Antibody (R1G11)

Catalog #:   RHB49001 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: IF, IP, WB
Accession: O94925
Overview

Catalog No.

RHB49001

Species reactivity

Human, Mouse, Rat

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Tested applications

IF: 1:50-1:200, IP: 1:20, WB: 1:500-1:1000

Target

GLS1, Glutaminase kidney isoform, mitochondrial, KIAA0838, GLS, L-glutamine amidohydrolase, K-glutaminase

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

O94925

Applications

IF, IP, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.

Clone ID

R1G11

Data Image
  • Immunofluorescence
    Immunocytochemistry analysis of Glutaminase (green) in A549 using Glutaminase antibody,and DAPI(blue).
  • Western blot
    Western blot analysis of Glutaminase C in rat brain lysates using Glutaminase C antibody.
  • Western blot
    Western blot analysis of Glutaminase in K562, 3T3, Hela lysates using Glutaminase antibody
References

A modular mRNA vaccine platform encoding antigen-presenting capsid virus-like particles enhances the immunogenicity of the malaria antigen Pfs25., PMID:40369344

Immunosequencing identifies signatures of T cell responses for early detection of nasopharyngeal carcinoma., PMID:40345188

Evolving Myocardial Injury in Chronic Kidney Disease Assessed by Multiparameter Magnetic Resonance in a Rabbit Model., PMID:40114358

Microcirculatory Dysfunction and Its Role in Diagnosing Acute Rejection in Pediatric Heart Transplantation: A Pilot Study., PMID:40075793

AKR1D1 suppresses liver cancer progression by promoting bile acid metabolism-mediated NK cell cytotoxicity., PMID:40010348

Incremental value of multiparametric cardiac magnetic resonance imaging for non-invasive identification of significant acute cardiac allograft rejection: a prospective and biopsy-proven study., PMID:39935182

Characterization of Hospital Admissions During Immune Checkpoint Inhibitor Therapy: Insights From the ICOG Study., PMID:39865401

Pharmacological blocking of microfibrillar-associated protein 4 reduces retinal neoangiogenesis and vascular leakage., PMID:39863929

Arbovirus exposure and subclinical myocardial dysfunction in an Indigenous population in Northeast Brazil: a cross-sectional study., PMID:39833670

The association of BMI and subclinical myocardial dysfunction in breast cancer patients after single or dual anti-HER2 targeted therapy., PMID:39734198

c-MET and the immunological landscape of cancer: novel therapeutic strategies for enhanced anti-tumor immunity., PMID:39664377

Right ventricular strain as a predictor of trastuzumab-induced chemotherapy-related cardiac dysfunction: A meta-analysis., PMID:39528123

Impact of metabolism-related markers on outcomes in ovarian cancer patients: Findings of the MITO16A/MaNGO-OV2 trial., PMID:39513196

Inhibition of Glutamate-to-Glutathione Flux Promotes Tumor Antigen Presentation in Colorectal Cancer Cells., PMID:39482885

PRX004 in variant amyloid transthyretin (ATTRv) amyloidosis: results of a phase 1, open-label, dose-escalation study., PMID:39472768

Antigen targeting and anti-tumor activity of a novel anti-CD146 212Pb internalizing alpha-radioimmunoconjugate against malignant peritoneal mesothelioma., PMID:39472474

EVALUATION OF LEFT VENTRICULAR SYSTOLIC FUNCTION IN POSTMENOPAUSAL WOMEN WITH BREAST CANCER RECEIVING ADJUVANT ANTHRACYCLINE AND TRASTUZUMAB THERAPY: A 2-YEAR FOLLOW-UP STUDY., PMID:39441311

Designed endocytosis-inducing proteins degrade targets and amplify signals., PMID:39322662

Investigation of the effect of intravitreal bevacizumab treatment on left heart function using speckle tracking echocardiography., PMID:39216529

HMGA2-mediated glutamine metabolism is required for Cd-induced cell growth and cell migration., PMID:39032683

Myocardial Characteristics, Cardiac Structure, and Cardiac Function in Systemic Light-Chain Amyloidosis., PMID:39001736

Combinational zimberelimab plus lenvatinib and chemotherapy for alpha-fetoprotein elevated, advanced gastric cancer patients (AFPGC): a phase 1 dose-escalation study., PMID:38833154

Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myeloma., PMID:38802346

Antigen escape as a shared mechanism of resistance to BCMA-directed therapies in multiple myeloma., PMID:38728378

Role of Early Left Atrial Functional Decline in Predicting Cardiotoxicity in HER2 Positive Breast Cancer Patients Treated With Trastuzumab., PMID:38696070

Unscheduled health care interactions in patients with multiple myeloma receiving T-cell redirection therapies., PMID:38621239

Longitudinal Echocardiographic Follow-Up of a Pediatric Multisystem Inflammatory Syndrome Cohort., PMID:38573091

Exercise-based cardio-oncology rehabilitation for cardiotoxicity prevention during breast cancer chemotherapy: The ONCORE randomized controlled trial., PMID:38395212

Isolation, Molecular, and Histopathological Patterns of a Novel Variant of Infectious Bursal Disease Virus in Chicken Flocks in Egypt., PMID:38393116

Myocardial function using two dimension speckle-tracking echocardiography in children with celiac disease., PMID:38060017

Cardiac dysfunction and their determinants in patients treated for breast cancer and lymphoma: A cardio-oncology center experience., PMID:37913931

CD8 effector T cells enhance teclistamab response in BCMA-exposed and -naïve multiple myeloma., PMID:37878808

Efficacy and safety of zimberelimab (GLS-010) monotherapy in patients with recurrent or metastatic cervical cancer: a multicenter, single-arm, phase II study., PMID:37875323

Microfibrillar-associated protein 4 as a potential marker of acute relapse in inflammatory demyelinating diseases of the central nervous system: Pathological and clinical aspects., PMID:37830484

Designed Endocytosis-Triggering Proteins mediate Targeted Degradation., PMID:37781607

Immune-Checkpoint Inhibitor-Related Myocarditis: Where We Are and Where We Will Go., PMID:37699402

First study demonstrating speckle tracking echocardiography has prognostic value in patients with idiopathic inflammatory myopathies., PMID:37592086

Benralizumab Prevents Recurrent Exacerbations in Patients with Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis., PMID:37533773

A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma., PMID:37319432

Immune response enhancement with GLS-5310 DNA primary vaccine against SARS-CoV-2 followed by administration of an mRNA vaccine heterologous boost., PMID:37296017

Quantitative cardiovascular magnetic resonance findings and clinical risk factors predict cardiovascular outcomes in breast cancer patients., PMID:37252927

Evaluation of left ventricular function of pregnant women with autoimmune diseases using speckle tracking echocardiography., PMID:37249654

Longitudinal assessment of cardiac parameters through MRI in breast cancer patients treated with anti-HER2 therapy., PMID:37183212

Three-Year Outcomes Following Permissive Cardiotoxicity in Patients on Trastuzumab., PMID:37094996

Left ventricular function changes and echocardiographic predictors in adult survivors of fulminant myocarditis treated with the Chinese protocol., PMID:37072479

Safety and immunogenicity of the ChAdOx1, MVA-MERS-S, and GLS-5300 DNA MERS-CoV vaccines., PMID:37004348

Potential Role of Global Longitudinal Strain in Cardiac and Oncological Patients Undergoing Cardio-Oncology Rehabilitation (CORE)., PMID:36961060

Seven-year outcomes following intensive anti-vascular endothelial growth factor therapy in patients with exudative age-related macular degeneration., PMID:36932356

Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial., PMID:36868261

Prognostic value of left ventricular global longitudinal strain on speckle echocardiography for predicting chemotherapy-induced cardiotoxicity in breast cancer patients: A systematic review and meta-analysis., PMID:36859694

Datasheet

Document Download

Anti-GLS Antibody (R1G11).pdf

 

$ 290
Product specifications
50 μg 290 100 μg 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-GLS Antibody (R1G11) [RHB49001]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only